Back to today’s briefing

Story perspectives

Obstructive Sleep Apnea Market to Surge 17% by 2034

1/7/2025

38 6

Summary

Story summary

The Obstructive Sleep Apnea (OSA) market, currently valued at around USD 359 million, is set to soar with a remarkable 17% growth rate projected by 2034. The United States alone represents over half of diagnosed cases, highlighting the urgent need for innovative treatments like Eli Lilly's tirzepatide and AD109, which are on the horizon to combat this growing health challenge.

1 of 1

Story summary

The Obstructive Sleep Apnea (OSA) market, currently valued at around USD 359 million, is set to soar with a remarkable 17% growth rate projected by 2034. The United States alone represents over half of diagnosed cases, highlighting the urgent need for innovative treatments like Eli Lilly's tirzepatide and AD109, which are on the horizon to combat this growing health challenge.